| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-10 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.26 | 7e-10 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-08 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.26 | 3e-07 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-06 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-06 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-06 |